Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes. (2019)

First Author: Walker VM
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15334.2

PubMed Identifier: 31448343

Publication URI: http://europepmc.org/abstract/MED/31448343

Type: Journal Article/Review

Volume: 4

Parent Publication: Wellcome open research

ISSN: 2398-502X